Bill > AJR32

This resolution seeks to designate the first full week in May as Tardive Dyskinesia (TD) Awareness Week, highlighting the importance of understanding this medical condition associated with long-term antipsychotic medication use. The resolution provides context about TD, noting it is a neurological disorder characterized by involuntary, repetitive movements affecting various body parts, which can occur in patients treating serious mental health conditions like bipolar disorder, major depressive disorder, and schizophrenia. It emphasizes that approximately 60 percent of the estimated 800,000 U.S. adults with TD remain undiagnosed, and certain populations are at higher risk, including individuals over 55, Black individuals, women, and those with mood or substance use disorders. The resolution underscores the American Psychiatric Association's recommendation for routine TD screening and encourages healthcare providers, patients, and care partners to be aware of TD risks, symptoms, and potential FDA-approved treatments. By designating a specific awareness week, the resolution aims to promote education, early detection, and improved understanding of this potentially stigmatizing condition that can significantly impact patients' physical, social, and emotional well-being.

https://docs.legis.wisconsin.gov/2025/proposals/reg/asm/joint_resolution/ajr32